お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1000968

喘息薬市場調査レポート:製品別(長期管理薬、アレルギー誘発性喘息治療薬、およびクイックリリーフ薬)、用途別-2025年までの予測-COVID-19の累積的影響

Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications ), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
喘息薬市場調査レポート:製品別(長期管理薬、アレルギー誘発性喘息治療薬、およびクイックリリーフ薬)、用途別-2025年までの予測-COVID-19の累積的影響
出版日: 2021年04月12日
発行: 360iResearch LLP
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の喘息治療薬の市場規模は、2020年の148億3,758万米ドルから、2025年末までに213億8,279万米ドルに成長すると予想されています。

COVID-19は、未曾有の世界的な公衆衛生上の緊急事態であり、あらゆる業界に影響を及ぼしてきました。この長期的影響は、予測期間中に業界の成長に影響を与えると予測されています。私たちが進めている調査では、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げています。当レポートは、消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19について洞察を提供しています。アップデートされた調査では、COVID-19が市場に及ぼす影響を考慮し、洞察、分析、予測などを提供しています。

当レポートでは、喘息薬市場について調査し、市場の概要とともに、製品別、用途別、地域別の動向、COVID-19の累積的影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画作成
    • 実行:調査実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 製品別見通し
  • 用途別見通し
  • 地域別見通し
  • 競合他社別見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 世界の喘息治療薬市場、製品別

  • 長期管理薬
  • アレルギー誘発性喘息治療薬
  • クイックリリーフ薬(レスキュー薬)

第7章 世界の喘息治療薬市場、用途別

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第8章 南北アメリカの喘息薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の喘息治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第10章 欧州、中東・アフリカの喘息治療薬市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第12章 企業のユーザビリティプロファイル

  • Aerocrine (Circassia)
  • ALK-Abello A/S
  • Amphastar Pharmaceuticals, Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Camber Pharmaceuticals
  • Chiesi Farmaceutici
  • Cipla
  • Cohero Health
  • GlaxoSmithKline PLC
  • Inspiro Medical (Opko Health)
  • Lallemand Pharma International
  • Merck & Co., Inc.
  • MundiPharma
  • Novartis AG
  • Pulmatrix
  • Roche Holding AG
  • Sanner GmbH
  • Sanofi/Regeneron
  • Sunovion
  • Teva
  • Theravance Biopharma|Mylan Inc.
  • Vectura Group plc
  • Verona Pharma plc

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASTHMA DRUGS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ASTHMA DRUGS MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL ASTHMA DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 9. GLOBAL ASTHMA DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
  • FIGURE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2025
  • FIGURE 13. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
  • FIGURE 17. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2025
  • FIGURE 19. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 23. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 25. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 26. BRAZIL ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 27. CANADA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 28. MEXICO ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 29. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 30. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 31. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 33. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. CHINA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. INDIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. INDONESIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. JAPAN ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 38. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. THAILAND ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 43. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 45. FRANCE ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. GERMANY ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. ITALY ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. QATAR ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. RUSSIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. SPAIN ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. GLOBAL ASTHMA DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 57. GLOBAL ASTHMA DRUGS MARKET: MARKET SHARE ANALYSIS
  • FIGURE 58. GLOBAL ASTHMA DRUGS MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ASTHMA DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. BRAZIL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. CANADA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CANADA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. MEXICO ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CHINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CHINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. INDIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. INDIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. INDONESIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. INDONESIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. JAPAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. JAPAN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. THAILAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. THAILAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. FRANCE ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. FRANCE ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. GERMANY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. GERMANY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. ITALY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. ITALY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. QATAR ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. QATAR ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. RUSSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. RUSSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. SPAIN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SPAIN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. GLOBAL ASTHMA DRUGS MARKET: SCORES
  • TABLE 71. GLOBAL ASTHMA DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 72. GLOBAL ASTHMA DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 73. GLOBAL ASTHMA DRUGS MARKET: RANKING
  • TABLE 74. GLOBAL ASTHMA DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 75. GLOBAL ASTHMA DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 76. GLOBAL ASTHMA DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 77. GLOBAL ASTHMA DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 78. GLOBAL ASTHMA DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 79. GLOBAL ASTHMA DRUGS MARKET: LICENSE & PRICING
目次
Product Code: MRR-DA05233

Title:
Asthma Drugs Market Research Report by Product (Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications (rescue medications)), by Application (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) - Global Forecast to 2025 - Cumulative Impact of COVID-19.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Asthma Drugs Market is expected to grow from USD 14,837.58 Million in 2020 to USD 21,382.79 Million by the end of 2025.

2. The Global Asthma Drugs Market is expected to grow from EUR 13,009.87 Million in 2020 to EUR 18,748.83 Million by the end of 2025.

3. The Global Asthma Drugs Market is expected to grow from GBP 11,565.80 Million in 2020 to GBP 16,667.75 Million by the end of 2025.

4. The Global Asthma Drugs Market is expected to grow from JPY 1,583,545.77 Million in 2020 to JPY 2,282,085.53 Million by the end of 2025.

5. The Global Asthma Drugs Market is expected to grow from AUD 21,546.13 Million in 2020 to AUD 31,050.65 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Asthma Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Asthma Drugs Market studied across Long-term control medications, Medications for allergy-induced asthma, and Quick-relief medications (rescue medications).

Based on Application, the Asthma Drugs Market studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Based on Geography, the Asthma Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Asthma Drugs Market including Aerocrine (Circassia), ALK-Abello A/S, Amphastar Pharmaceuticals, Inc., AstraZeneca, Boehringer Ingelheim, Camber Pharmaceuticals, Chiesi Farmaceutici, Cipla, Cohero Health, GlaxoSmithKline PLC, Inspiro Medical (Opko Health), Lallemand Pharma International, Merck & Co., Inc., MundiPharma, Novartis AG, Pulmatrix, Roche Holding AG, Sanner GmbH, Sanofi/Regeneron, Sunovion, Teva, Theravance Biopharma|Mylan Inc., Vectura Group plc, and Verona Pharma plc.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Asthma Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Asthma Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Asthma Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Asthma Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Asthma Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Asthma Drugs Market?

6. What are the modes and strategic moves considered suitable for entering the Global Asthma Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of asthma globally
      • 5.1.1.2. Increasing acceptance of asthma drugs with approval from FDA
      • 5.1.1.3. Government initiatives fuels the awareness of asthma drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Expiry of patent drugs and high penetration of generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the development of asthma drugs
      • 5.1.3.2. Introduction of generic drugs in developing regions
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for the approval of asthma drugs
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Asthma Drugs Market, By Product

  • 6.1. Introduction
  • 6.2. Long-term control medications
  • 6.3. Medications for allergy-induced asthma
  • 6.4. Quick-relief medications (rescue medications)

7. Global Asthma Drugs Market, By Application

  • 7.1. Introduction
  • 7.2. Hospital Pharmacy
  • 7.3. Online Pharmacy
  • 7.4. Retail Pharmacy

8. Americas Asthma Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Asthma Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Asthma Drugs Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Aerocrine (Circassia)
  • 12.2. ALK-Abello A/S
  • 12.3. Amphastar Pharmaceuticals, Inc.
  • 12.4. AstraZeneca
  • 12.5. Boehringer Ingelheim
  • 12.6. Camber Pharmaceuticals
  • 12.7. Chiesi Farmaceutici
  • 12.8. Cipla
  • 12.9. Cohero Health
  • 12.10. GlaxoSmithKline PLC
  • 12.11. Inspiro Medical (Opko Health)
  • 12.12. Lallemand Pharma International
  • 12.13. Merck & Co., Inc.
  • 12.14. MundiPharma
  • 12.15. Novartis AG
  • 12.16. Pulmatrix
  • 12.17. Roche Holding AG
  • 12.18. Sanner GmbH
  • 12.19. Sanofi/Regeneron
  • 12.20. Sunovion
  • 12.21. Teva
  • 12.22. Theravance Biopharma|Mylan Inc.
  • 12.23. Vectura Group plc
  • 12.24. Verona Pharma plc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.